Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Shock for Life and HeartSine® Technologies Now Exclusive Providers of Lifesaving AED Solution to Wegmans Food Markets

August 30, 2011 12:34 pm | by Bio-Medicine.Org | News | Comments

NEWTOWN, Pa., Aug. 30, 2011 /- HeartSine ® Technologies, Inc. ( www.heartsine.com ), a world leader in personal and public access defibrillators, announced today that Wegmans Food Markets, Inc. has selected  the HeartSine Automated External Defibrillator (AED) as the...

MedInformatix' Practice Management and Electronic Medical Records Solution Streamlines The Family Doctors of Belleview's High Daily Patient Volumes

August 30, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

BELLEVIEW, Fla., Aug. 30, 2011 /- Much like yesteryear's family doctor or general practitioner, The Family Doctors of Belleview's eight board-certified Primary Care physicians and two physician assistants (PAs) serve most every healthcare need in the Florida city town bearing its name and...

Hospitals Evacuated in Preparation for Hurricane Irene with Aid of Pulse Oximeter

August 30, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., Aug. 30, 2011 /- Hurricane Irene came rushing up the East Coast as a Category One. As the storm left the Caribbean and approached the United States, many states in the Northeast began to worry. The coastline north of Virginia and even Maryland, is not prone to hurricanes....

Advertisement

Masimo Pronto-7â„¢ Receives Japanese and Canadian Regulatory Clearances

August 29, 2011 10:33 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Aug. 29, 2011 /- Masimo (NASDAQ: MASI ) today announced the Japanese Ministry of Health Labor & Welfare (MHLW) and Health Canada regulatory clearances of Masimo Pronto-7™— enabling clinicians throughout Japan and Canada to quickly and conveniently...

Bioness Inc Announces Availability of L300 Plus System

August 29, 2011 7:34 am | by Bio-Medicine.Org | News | Comments

VALENCIA, Calif., Aug. 29, 2011 /- Bioness Inc., today announced the commercial release of its NESS L300® Plus System. Cleared by the U.S. Food and Drug Administration (FDA) earlier this year, the L300 Plus combines the award winning NESS L300® Foot Drop System with a thigh cuff...

Masimo to Present at Morgan Stanley Global Healthcare Conference

August 29, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Aug. 29, 2011 /- Masimo (NASDAQ: MASI ) today announced that its management is scheduled to present at the Morgan Stanley Global Healthcare Conference at the Grand Hyatt New York on Tuesday, September 13, 2011, at 1:35 p.m. Eastern Time.  A live audiocast of the...

Philips Unveils a Vision for the Future of Cardiac Care at ESC 2011

August 28, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

PARIS, August 28, 2011 /- From 3D Simulated Heart Surgery and Digitized Patient Discharge Planning, to the World's First Sleep Apnea Mobile App for Cardiologists - Philips gets to the Heart of Innovation Royal Philips Electronics (NYSE: PHG, AEX: PHI) will provide clinicians from...

Urgent Call Is Issued for More Local Doctors and Nurses for Monday's Free Health Clinic

August 26, 2011 12:34 pm | by Bio-Medicine.Org | News | Comments

NEW ORLEANS, Aug. 26, 2011 /- Organizers of Monday's massive, one-day, free medical clinic at the Ernest N. Morial Convention Center in New Orleans are urging more local doctors and advanced practice nurses to volunteer, because travel problems related to Hurricane Irene along the East...

Advertisement

Boehringer Ingelheim to Launch RE-ALIGNâ„¢ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves

August 26, 2011 6:45 am | by Bio-Medicine.Org | News | Comments

RIDGEFIELD, Conn., Aug. 26, 2011 /- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced plans to launch RE-ALIGN™, a global, Phase II trial evaluating the safety and pharmacokinetics of dabigatran etexilate in 400 patients who have mechanical heart valves.(1) The...

Preliminary Lineup of Presenters Set for 7th Annual New York Stem Cell Summit

August 25, 2011 10:40 am | by Bio-Medicine.Org | News | Comments

PHILADELPHIA, Aug. 25, 2011 /- RRY Publications LLC today announced the preliminary lineup of presenters for the 7th Annual Stem Cell Summit. The Stem Cell Summit, an intensive one-day event, that allows attendees to learn about the latest developments in the stem cell marketplace,...

Stereotaxis to Present at the Stifel Nicolaus Healthcare Conference on September 7, 2011

August 25, 2011 8:39 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Aug. 25, 2011 /- Stereotaxis, Inc. (NASDAQ: STXS ) today announced that executive management will present at the Stifel Nicolaus Healthcare Conference to be held September 7-9, 2011 in Boston, MA.  Michael P. Kaminski, President and Chief Executive Officer of Stereotaxis,...

HeartSine® Technologies Donates Lifesaving AED to Camphill Special School

August 24, 2011 9:45 am | by Bio-Medicine.Org | News | Comments

NEWTOWN, Pa., Aug. 24, 2011 /- HeartSine® Technologies, Inc. ( www.heartsine.com ), a world leader in personal and public access defibrillators, announced the donation of the samaritan ® PAD 300P Public Access Defibrillator to Camphill Special School, a community and a school...

Framingham Heart study leader, Kannel, dies

August 24, 2011 5:43 am | by Mass High Tech: The Journal of New England Technology | News | Comments

One of the driving forces of the long-running, pioneering project known as the Framingham Heart Study died of cancer on Saturday at age 87.

Advertisement

VeraLight and Pear Healthcare Solutions Sign Canadian Distribution Agreement for SCOUT DS® Noninvasive Diabetes Screening Device

August 23, 2011 4:48 am | by Bio-Medicine.Org | News | Comments

ALBUQUERQUE, N.M. and TORONTO, Aug. 23, 2011 /- VeraLight Inc., the first company to develop an optical skin measurement for noninvasive diabetes screening, and Pear Healthcare Solutions Inc., a leading provider of in-pharmacy health screening and education services, today announced an...

Growing Heart Cells Just for You

August 22, 2011 8:45 pm | by Massachusetts Institute of Technology | News | Comments

What can heart cells generated from my blood tell me about my risk for disease-and about what drugs I should take if I get sick?

Visiting Wisconsin to See My Heart

August 22, 2011 8:44 pm | by Massachusetts Institute of Technology | News | Comments

David traveled to the headquarters of CDI in Madison to view his stem cells and his beating heart cells–and to meet the lab team who made and tested them.

Spaulding Clinical Announces Strategic Partnership with Clinigene International, India for Providing Comprehensive Early Clinical Solutions to Pharmaceutical and Biotech Clien...

August 22, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

WEST BEND, Wis., Aug. 22, 2011 /- Clinigene International Limited, an India-based Central and Bioanalytical Laboratory and Phase I-IV Clinical Research Organization, and Spaulding Clinical Research, LLC, US-based leading-edge Clinical Pharmacology, Cardiac Core Lab, and Medical Device...

First UK Patient Enrolled into Luminous™ Programme – Novartis' 30,000 Patient Observational Study in Ophthalmology

August 21, 2011 11:41 pm | by RealWire | News | Comments

Luminous, launched today, will provide long-term effectiveness, safety, and patient reported outcome data on Lucentis® (ranibizumab) in 30,000 patients in real-life settings across the worldFrimley, August 22 2011 - Novartis Pharmaceuticals UK Ltd (Novartis) has announced the...

The Leukemia & Lymphoma Society Available to Comment on FDA Approval of Seattle Genetics' Adcetris, First New Treatment for Hodgkin Lymphoma Since 1977

August 19, 2011 5:45 pm | by Bio-Medicine.Org | News | Comments

WHITE PLAINS, N.Y., Aug. 19, 2011 /- Today the Food and Drug Administration (FDA) approved Seattle Genetics' Adcetris to treat two types of rare blood cancers – Hodgkin lymphoma and anaplastic large cell lymphoma (ALCL). (Logo: http://photos.prnewswire.com/prnh/20110215/NY48642LOGO)...

Tips for Reducing the Signs of Arthritis in Pets

August 18, 2011 11:42 am | by Bio-Medicine.Org | News | Comments

PLYMOUTH MEETING, Pa., Aug. 18, 2011 /- According to the Arthritis Foundation, arthritis affects one in every five adult dogs in the United States and is one of the most common sources of chronic pain that veterinarians treat. Pet owners can easily be overwhelmed by the variety of...

Polymedco Announces Publication in Epidemiologic Reviews

August 17, 2011 9:42 am | by Bio-Medicine.Org | News | Comments

CORTLANDT MANOR, N.Y., Aug. 17, 2011 /- Polymedco is pleased to announce a publication in Epidemiologic Review, "Organized Colorectal Cancer Screening in Integrated Health Care Systems" by Theodore R Levin, Laura Jamieson, Daniel A Burley, Juan Reyes, Michael Oehrli, and Cindy Caldwell...

Two-Year Follow-Up Data Show Outstanding Clinical Outcomes and Safety for OrbusNeich's Genousâ„¢ Stent in Patients at High Risk for Restenosis

August 16, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

HONG KONG, Aug. 16, 2011 /- OrbusNeich today announced that the that the company's Genous Stent showed no significant difference in the rate of target vessel failure (TVF) at two years compared to the Taxus Liberte™ paclitaxel-eluting stent in patients with de novo coronary artery...

CR Magazine Congratulates Cynthia Ryan, Ph.D., Clarion Award Recipient

August 16, 2011 6:40 am | by AACR | News | Comments

Tweet PHILADELPHIA — CR magazine, the AACR’s magazine for cancer survivors, their families and caregivers, congratulates contributing writer Cynthia Ryan, Ph.D., on her Clarion Award-winning article, “Homeless With Cancer,” which was published in CR’s Fall...

New Study Shows Modified Citrus Pectin Activates Powerful Immune Responses

August 16, 2011 2:43 am | by Bio-Medicine.Org | News | Comments

SANTA ROSA, Calif., Aug. 16, 2011 /- Groundbreaking research demonstrates the ability of a specific form of Modified Citrus Pectin (MCP) to greatly enhance immune function. The study found that MCP activated B-cells in a dose-dependent manner, and induced a highly significant...

THA Group Partners with Cardiocom Telehealth

August 15, 2011 6:47 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, Aug. 15, 2011 /- THA Group, a free standing in-home health company serving coastal Georgia and South Carolina, announced that it will be partnering with Cardiocom® to expand its chronic telehealth program providing advanced home telehealth technology to patients with...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading